Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16167 | 28527304 | Diabetes Res Clin Pract | Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome. | 2017 | Details |
| A16168 | 28526997 | Adv Ther | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. | 2017 | Details |
| A16169 | 28526925 | Eur J Nutr | Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells. | 2017 | Details |
| A16170 | 28526812 | Oncotarget | Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. | 2017 | Details |
| A16171 | 28525362 | Horm Mol Biol Clin Investig | FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. | 2017 | Details |
| A16172 | 28524171 | Nat Rev Endocrinol | Endocrine-disrupting chemicals and fatty liver disease. | 2017 | Details |
| A16173 | 28523578 | Dig Dis Sci | Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16174 | 28521872 | Metabolism | Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. | 2017 | Details |
| A16175 | 28521870 | Metabolism | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. | 2017 | Details |
| A16176 | 28521774 | J Transl Med | Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease. | 2017 | Details |
| A16177 | 28521680 | Curr Med Chem | Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis. | 2019 | Details |
| A16178 | 28520503 | Metab Syndr Relat Disord | Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014. | 2017 | Details |
| A16179 | 28518142 | Cell Death Dis | MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. | 2017 | Details |
| A16180 | 28515456 | Sci Rep | Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet. | 2017 | Details |
| A16181 | 28515357 | JCI Insight | E2F1 inhibits circulating cholesterol clearance by regulating Pcsk9 expression in the liver. | 2017 | Details |
| A16182 | 28514835 | Biomed Pharmacother | Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. | 2017 | Details |
| A16185 | 28512251 | Mol Cancer Res | Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation. | 2017 | Details |
| A16186 | 28511733 | Nutr Res Rev | Similarities and interactions between the ageing process and high chronic intake of added sugars. | 2017 | Details |
| A16188 | 28511199 | Inflamm Bowel Dis | Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. | 2017 | Details |
| A16189 | 28511168 | Wiad Lek | [The nonalcoholic steatohepatitis influence on the course and progression of ischemic heart disease]. | 2017 | Details |
| A16190 | 28511163 | Wiad Lek | [Impact of physical activity on anthropometric indices in patients with nonalcoholic fatty liver disease and pre-diabetes or type 2 diabetes]. | 2017 | Details |
| A16191 | 28511161 | Wiad Lek | [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity]. | 2017 | Details |
| A16192 | 28511152 | Wiad Lek | [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes]. | 2017 | Details |
| A16193 | 28511023 | Appl Physiol Nutr Metab | Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial. | 2017 | Details |
| A16194 | 28511018 | Appl Physiol Nutr Metab | Daytime increase in caloric intake without change in total 24-h caloric intake can increase adiposity but not total bodyweight in rats with inverted feeding pattern. | 2016 | Details |
| A16195 | 28510581 | PLoS One | Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. | 2017 | Details |
| A16196 | 28509327 | Int J Cancer | The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease. | 2017 | Details |
| A16197 | 28508477 | Hepatology | The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. | 2017 | Details |
| A16198 | 28508194 | Endocrine | Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. | 2017 | Details |
| A16199 | 28508193 | Endocrine | Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice. | 2017 | Details |
| A16200 | 28507930 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature. | 2017 | Details |
| A16201 | 28507929 | J Clin Transl Hepatol | Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies. | 2017 | Details |
| A16202 | 28507837 | Cureus | Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias. | 2017 | Details |
| A16203 | 28507473 | EXCLI J | Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease. | 2017 | Details |
| A16204 | 28507343 | Sci Rep | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. | 2017 | Details |
| A16205 | 28507283 | Med Sci Monit | MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR). | 2017 | Details |
| A16206 | 28506907 | J Hepatol | Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. | 2017 | Details |
| A16207 | 28506744 | Adv Drug Deliv Rev | Hepatic stellate cells as key target in liver fibrosis. | 2017 | Details |
| A16208 | 28506365 | Gastroenterol Clin North Am | Drug-induced Liver Injury: The Hepatic Pathologist's Approach. | 2017 | Details |
| A16209 | 28506362 | Gastroenterol Clin North Am | Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16210 | 28506338 | Zhongguo Dang Dai Er Ke Za Zhi | [Clinical efficacy of compound glycyrrhizin tablets in the treatment of children with nonalcoholic fatty liver disease]. | 2017 | Details |
| A16211 | 31646122 | Cardiovasc Endocrinol | Nonalcoholic fatty liver disease: implications for cardiovascular risk. | 2017 | Details |
| A16212 | 28505074 | Nutrients | NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. | 2017 | Details |
| A16213 | 28504910 | J Med Food | Fermented Moringa oleifera Decreases Hepatic Adiposity and Ameliorates Glucose Intolerance in High-Fat Diet-Induced Obese Mice. | 2017 | Details |
| A16214 | 28504497 | Arch Argent Pediatr | Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update. | 2017 | Details |
| A16215 | 28504310 | J Physiol | Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis. | 2017 | Details |
| A16216 | 28503750 | Diabetes Obes Metab | Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. | 2017 | Details |
| A16218 | 28503502 | Adv Biomed Res | Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran. | 2017 | Details |
| A16219 | 28503495 | Adv Biomed Res | The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2017 | Details |
| A16221 | 28502513 | J Clin Lipidol | Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia. | 2017 | Details |
| A16222 | 28502444 | Pediatr Clin North Am | Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications. | 2017 | Details |
| A16224 | 28501537 | Clin Gastroenterol Hepatol | Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. | 2017 | Details |
| A16225 | 28501229 | Prim Care | Integrative Medicine for Gastrointestinal Disease. | 2017 | Details |
| A16226 | 28500084 | J Endocrinol | Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice. | 2017 | Details |
| A16227 | 28499273 | Oncotarget | Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development. | 2017 | Details |
| A16228 | 28498022 | Curr Med Res Opin | Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. | 2017 | Details |
| A16229 | 28497760 | Lancet Gastroenterol Hepatol | The intestinal microbiome and paediatric liver disease. | 2017 | Details |
| A16230 | 28497593 | J Gastroenterol Hepatol | Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease. | 2018 | Details |
| A16231 | 28496045 | J Atheroscler Thromb | Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs. | 2017 | Details |
| A16233 | 28494548 | Zhonghua Gan Zang Bing Za Zhi | [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis]. | 2017 | Details |
| A16234 | 28494529 | Clin Mol Hepatol | NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs. | 2017 | Details |
| A16235 | 28493399 | Echocardiography | Diagnosis of fatty liver by computed tomography coronary artery calcium score. | 2017 | Details |
| A16236 | 28493388 | Hepatology | Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. | 2017 | Details |
| A16237 | 28492501 | Nutrients | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. | 2017 | Details |
| A16238 | 28490707 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease]. | 2017 | Details |
| A16239 | 28490610 | Diabetes | Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. | 2017 | Details |
| A16240 | 28489307 | Liver Int | Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey. | 2017 | Details |
| A16241 | 28489136 | Rev Assoc Med Bras (1992) | Hyperferritinemia in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16242 | 28488513 | Nurs Stand | High or low birth weight may increase risk of liver disease. | 2017 | Details |
| A16243 | 28487615 | World J Gastroenterol | Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. | 2017 | Details |
| A16244 | 28487551 | Int J Obes (Lond) | High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. | 2017 | Details |
| A16245 | 28486193 | Biomed Pharmacother | Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro. | 2017 | Details |
| A16246 | 28484681 | Cureus | Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis. | 2017 | Details |
| A16247 | 28484247 | Sci Rep | Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. | 2017 | Details |
| A16253 | 28483554 | Biochim Biophys Acta Mol Cell Biol Lipids | Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease. | 2017 | Details |
| A16255 | 28483030 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Value and Progress of Ultrasound in Diagnosis and Treatment of Hyperuricemia. | 2017 | Details |
| A16256 | 28482789 | Curr Med Chem | Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver. | 2019 | Details |
| A16257 | 28482404 | Zhonghua Gan Zang Bing Za Zhi | [Research advances in nonalcoholic fatty liver disease and alcoholic liver disease in 2016]. | 2017 | Details |
| A16258 | 28481662 | Metab Syndr Relat Disord | The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16259 | 28481357 | Nat Med | Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4. | 2017 | Details |
| A16260 | 28481195 | Radiology | Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging. | 2017 | Details |
| A16262 | 28480888 | Nat Commun | Hepatic p63 regulates steatosis via IKKβ/ER stress. | 2017 | Details |
| A16263 | 28480679 | Isr Med Assoc J | Relationship between Non-Alcoholic Fatty Liver Disease and Breast Cancer. | 2017 | Details |
| A16264 | 28479504 | Clin Gastroenterol Hepatol | Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. | 2017 | Details |
| A16265 | 28479502 | Clin Gastroenterol Hepatol | Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. | 2017 | Details |
| A16266 | 28479500 | Clin Gastroenterol Hepatol | Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16267 | 28478385 | J Biol Chem | Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. | 2017 | Details |
| A16268 | 28476236 | Endocrinol Metab Clin North Am | Genetics of Lipodystrophy. | 2017 | Details |
| A16269 | 28475150 | Int J Mol Sci | Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E. | 2017 | Details |
| A16270 | 28475023 | Acta Radiol | Acoustic radiation force impulse imaging for detection of liver fibrosis in overweight and obese children. | 2017 | Details |
| A16271 | 28474143 | Dig Dis Sci | Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma. | 2017 | Details |
| A16272 | 28473851 | Int J Endocrinol | Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients. | 2017 | Details |
| A16273 | 28473066 | J Am Coll Radiol | ACR Appropriateness Criteria® Chronic Liver Disease. | 2017 | Details |
| A16274 | 28473059 | Nutr Res | Nicotinamide protects hepatocytes against palmitate-induced lipotoxicity via SIRT1-dependent autophagy induction. | 2017 | Details |
| A16275 | 28472948 | BMC Gastroenterol | Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter. | 2017 | Details |
| A16276 | 28472600 | J Med Food | Glucomannan or Glucomannan Plus Spirulina-Enriched Squid-Surimi Diets Reduce Histological Damage to Liver and Heart in Zucker fa/fa Rats Fed a Cholesterol-Enriched and Non-Cholesterol-Enriched Atherogenic Diet. | 2017 | Details |
| A16277 | 28472477 | J Clin Endocrinol Metab | Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16278 | 28472039 | PLoS One | Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients. | 2017 | Details |
| A16279 | 28471965 | Medicine (Baltimore) | Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. | 2017 | Details |
| A16280 | 28471945 | AIDS | Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. | 2017 | Details |